{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-8784", "postId": 8784, "name": "Hercules Capital, Inc.", "description": "If you purchased or acquired securities in Hercules Capital between May 1, 2025 and February 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hercules Capital, Inc. (\u201cHercules Capital\u201d or the \u201cCompany\u201d) (NYSE: HTGC) and reminds investors of the May 19, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) the Company overstated the due diligence with which it conducted its portfolio valuation process; (3) the Company reported misclassified portfolio investments; (4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Lead Plaintiff Deadline: May 19, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.  ", "identifier": "HTGC", "legal": { "court": "United States District Court for the Northern District of California", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "05/01/2025", "end": "02/27/2026" }, "leadPlaintiffDeadline": "05/19/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/hercules-capital-inc/", "canonicalUrl": "https://faruqilaw.com/case/hercules-capital-inc/", "datePublished": "2026-03-23T14:43:47+00:00", "dateModified": "2026-03-23T14:43:47+00:00", "associatedOrganization": { "@id": "case-8784-org" }, "legalService": { "@id": "case-8784-legalservice" }, "hasPart": [ { "@id": "case-8784-faq" }, { "@id": "case-8784-press-list" } ], "legalRepresentation": [ { "@id": "case-8784-attorney-516" }, { "@id": "case-8784-attorney-506" } ] }, { "@type": "Organization", "@id": "case-8784-org", "name": "Hercules Capital, Inc.", "identifier": "HTGC", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://www.htgc.com/" }, { "@type": "LegalService", "@id": "case-8784-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-8784-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-8784-legalservice" } }, { "@type": "Person", "@id": "case-8784-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-8784-legalservice" } }, { "@type": "FAQPage", "@id": "case-8784-faq", "mainEntity": [ { "@type": "Question", "name": "Why is Hercules Capital facing a securities class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors allege Hercules Capital made misleading statements about its due diligence practices, loan origination, and portfolio valuation processes." } }, { "@type": "Question", "name": "What are investors claiming about Hercules Capital\u2019s due diligence?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges the company overstated how thoroughly it evaluated investments during deal sourcing and loan origination." } }, { "@type": "Question", "name": "What is the issue with Hercules Capital\u2019s portfolio valuations?", "acceptedAnswer": { "@type": "Answer", "text": "Investors claim the company misrepresented the value of its portfolio by overstating valuations and misclassifying certain investments." } }, { "@type": "Question", "name": "How could overstated valuations affect Hercules Capital\u2019s stock?", "acceptedAnswer": { "@type": "Answer", "text": "If assets are overvalued, the company may appear stronger than it is, leading to price corrections when the truth emerges." } }, { "@type": "Question", "name": "What are investors alleging Hercules Capital failed to disclose?", "acceptedAnswer": { "@type": "Answer", "text": "Plaintiffs claim the company did not fully disclose weaknesses in due diligence and valuation practices." } }, { "@type": "Question", "name": "Who may qualify to participate in the Hercules Capital class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased securities between May 1, 2025 and February 27, 2026 may be eligible if they suffered losses." } }, { "@type": "Question", "name": "What is the deadline to seek lead plaintiff status in the Hercules lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors seeking to serve as lead plaintiff must file a motion by May 19, 2026." } }, { "@type": "Question", "name": "What does the term \u201cclass period\u201d mean in a securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The class period is the timeframe when alleged misleading statements occurred and investors may have purchased the stock." } }, { "@type": "Question", "name": "Do investors need to pay legal fees to join a securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "Most cases are handled on contingency, meaning attorneys are paid only if there is a recovery." } }, { "@type": "Question", "name": "What is a lead plaintiff in a securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "The lead plaintiff is the investor appointed by the court to represent the interests of all shareholders in the case." } }, { "@type": "Question", "name": "How do investors receive compensation from a securities class action settlement?", "acceptedAnswer": { "@type": "Answer", "text": "If a settlement is reached, investors submit claim forms documenting their trades to receive a share of the settlement fund." } } ] }, { "@type": "NewsArticle", "@id": "case-8784-press-1", "headline": "Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS", "url": "https://www.stocktitan.net/news/HCXY/hercules-capital-receives-a-bbb-high-affirmed-investment-grade-z28ql95vyk0s.html", "datePublished": "2026-03-04" }, { "@type": "NewsArticle", "@id": "case-8784-press-2", "headline": "The Myth of Hercules Capital", "url": "https://hntrbrk.com/hercules-capital/", "datePublished": "2026-02-27" }, { "@type": "NewsArticle", "@id": "case-8784-press-3", "headline": "How The Hercules Capital (HTGC) Story Is Shifting As Analysts Rework Growth And Valuation Assumptions", "url": "https://finance.yahoo.com/news/hercules-capital-htgc-story-shifting-220936050.html", "datePublished": "2026-02-25" }, { "@type": "NewsArticle", "@id": "case-8784-press-4", "headline": "Hercules Capital Directors Buy Shares As Credit Risks And Dividends Draw Focus", "url": "https://simplywall.st/stocks/us/diversified-financials/nyse-htgc/hercules-capital/news/hercules-capital-directors-buy-shares-as-credit-risks-and-di", "datePublished": "2026-02-24" }, { "@type": "NewsArticle", "@id": "case-8784-press-5", "headline": "Hercules Capital: The Diamond Has Fallen Off A Cliff; Time To Pick It Up", "url": "https://seekingalpha.com/article/4871293-hercules-capital-the-diamond-has-fallen-off-a-cliff-time-to-pick-it-up", "datePublished": "2026-02-18" }, { "@type": "NewsArticle", "@id": "case-8784-press-6", "headline": "Hercules Capital: 3 Reasons Why The Market Is Wrong (Rating Upgrade)", "url": "https://seekingalpha.com/article/4870470-hercules-capital-3-reasons-why-the-market-is-wrong-rating-upgrade", "datePublished": "2026-02-15" }, { "@type": "NewsArticle", "@id": "case-8784-press-7", "headline": "Hercules Capital (HTGC) Stock Sinks As Market Gains: What You Should Know", "url": "https://finance.yahoo.com/news/hercules-capital-htgc-stock-sinks-230003804.html", "datePublished": "2026-02-02" }, { "@type": "ItemList", "@id": "case-8784-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-8784-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-8784-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-8784-press-3" } }, { "@type": "ListItem", "position": 4, "item": { "@id": "case-8784-press-4" } }, { "@type": "ListItem", "position": 5, "item": { "@id": "case-8784-press-5" } }, { "@type": "ListItem", "position": 6, "item": { "@id": "case-8784-press-6" } }, { "@type": "ListItem", "position": 7, "item": { "@id": "case-8784-press-7" } } ] } ] }

Hercules Capital, Inc.

Hercules Capital, Inc.

Join Action
Case Details
Filed On: March 23, 2026
Ticker HTGC
Class Period 05/01/2025 - 02/27/2026
Lead Plaintiff Deadline 05/19/2026
Days Left to Seek Plaintiff
-6

If you are a Hercules Capital investor who suffered a loss and would like to learn more, you can provide your information below:

If you purchased or acquired securities in Hercules Capital between May 1, 2025 and February 27, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hercules Capital, Inc. (“Hercules Capital” or the “Company”) (NYSE: HTGC) and reminds investors of the May 19, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company overstated the due diligence with which it conducted its deal sourcing and/or loan origination process; (2) the Company overstated the due diligence with which it conducted its portfolio valuation process; (3) the Company reported misclassified portfolio investments; (4) as a result of the foregoing, the Company overstated and/or misrepresented its portfolio valuations; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

📞 Lead Plaintiff Deadline: May 19, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

 

Join Action
Hercules Capital, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771